Swedish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs for the treatment of cancer.

Vicore Pharma Holding

Market Cap: SEK 1.9b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

AcuCort

Market Cap: SEK 199.9m

Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

Newbury Pharmaceuticals

Market Cap: SEK 71.4m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Elicera Therapeutics

Market Cap: SEK 249.5m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Lipigon Pharmaceuticals

Market Cap: SEK 14.2m

Develops drugs for lipid related diseases in Sweden.

AcouSort

Market Cap: SEK 67.5m

A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.

Camurus

Market Cap: SEK 31.0b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Abera Bioscience

Market Cap: SEK 118.2m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

Karolinska Development

Market Cap: SEK 269.6m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

Aptahem

Market Cap: SEK 12.8m

A biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions.

Respiratorius

Market Cap: SEK 24.7m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

Dextech Medical

Market Cap: SEK 99.8m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

Flerie

Market Cap: SEK 3.4b

A venture capital firm specializing in early-stage investments.

Bonesupport Holding

Market Cap: SEK 18.5b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

AroCell

Market Cap: SEK 130.4m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

Genovis AB (publ.)

Market Cap: SEK 1.7b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

BioGaia

Market Cap: SEK 10.5b

A healthcare company, provides probiotic products worldwide.

BioInvent International

Market Cap: SEK 2.1b

A clinical-stage company, discovers, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

BioArctic

Market Cap: SEK 18.2b

Develops biological drugs for patients with central nervous system disorders in Sweden.

SynAct Pharma

Market Cap: SEK 878.2m

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Promimic

Market Cap: SEK 341.0m

Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.

Biotage

Market Cap: SEK 11.4b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

Cinclus Pharma Holding

Market Cap: SEK 498.0m

A clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases.

CombiGene

Market Cap: SEK 50.7m

Engages in the development of gene therapy for severe life-altering diseases in Sweden.

Infant Bacterial Therapeutics

Market Cap: SEK 798.9m

Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.

Dicot Pharma

Market Cap: SEK 980.6m

Engages in the development of pharmaceutical products in Sweden.

Biosergen

Market Cap: SEK 137.1m

A biotech company, develops antifungal products.

Isofol Medical

Market Cap: SEK 193.8m

Operates as a clinical stage biotech company.

Enorama Pharma

Market Cap: SEK 178.4m

A pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden.

Intervacc

Market Cap: SEK 365.4m

Develops novel veterinary vaccines for animals in Sweden.

MedCap

Market Cap: SEK 6.8b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

Guard Therapeutics International

Market Cap: SEK 308.6m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Saniona

Market Cap: SEK 1.1b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Annexin Pharmaceuticals

Market Cap: SEK 260.3m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.